Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial.

AF, atrial fibrillation Clinical research Clinical trials Digital technology ECG, electrocardiographic ICF, informed consent form Outreach Remote enrollment Remote monitoring mSToPS, mHealth Screening to Prevent Strokes

Journal

Contemporary clinical trials communications
ISSN: 2451-8654
Titre abrégé: Contemp Clin Trials Commun
Pays: Netherlands
ID NLM: 101671157

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 24 10 2018
revised: 07 12 2018
accepted: 05 01 2019
entrez: 19 1 2019
pubmed: 19 1 2019
medline: 19 1 2019
Statut: epublish

Résumé

The advent of large databases, wearable technology, and novel communications methods has the potential to expand the pool of candidate research participants and offer them the flexibility and convenience of participating in remote research. However, reports of their effectiveness are sparse. We assessed the use of various forms of outreach within a nationwide randomized clinical trial being conducted entirely by remote means. Candidate participants at possibly higher risk for atrial fibrillation were identified by means of a large insurance claims database and invited to participate in the study by their insurance provider. Enrolled participants were randomly assigned to one of two groups testing a wearable sensor device for detection of the arrhythmia. Over 10 months, the various outreach methods used resulted in enrollment of 2659 participants meeting eligibility criteria. Starting with a baseline enrollment rate of 0.8% in response to an email invitation, the recruitment campaign was iteratively optimized to ultimately include website changes and the use of a five-step outreach process (three short, personalized emails and two direct mailers) that highlighted the appeal of new technology used in the study, resulting in an enrollment rate of 9.4%. Messaging that highlighted access to new technology outperformed both appeals to altruism and appeals that highlighted accessing personal health information. Targeted outreach, enrollment, and management of large remote clinical trials is feasible and can be improved with an iterative approach, although more work is needed to learn how to best recruit and retain potential research participants. Clinicaltrials.govNCT02506244. Registered 23 July 2015.

Identifiants

pubmed: 30656241
doi: 10.1016/j.conctc.2019.100318
pii: S2451-8654(18)30168-6
pii: 100318
pmc: PMC6329362
doi:

Banques de données

ClinicalTrials.gov
['NCT02506244']

Types de publication

Journal Article

Langues

eng

Pagination

100318

Références

IRB. 1998 Jul-Aug;20(4):1-7
pubmed: 11657084
Europace. 2009 Oct;11(10):1295-300
pubmed: 19648586
J Am Coll Cardiol. 2013 May 7;61(18):1935-44
pubmed: 23558044
J Clin Med Res. 2013 Jun;5(3):185-93
pubmed: 23671544
Acad Emerg Med. 2016 Jul;23(7):759-65
pubmed: 26990899
Am Heart J. 2016 May;175:77-85
pubmed: 27179726
Sci Transl Med. 2016 Jul 20;8(348):348fs13
pubmed: 27440726
Lancet. 2017 Nov 11;390(10108):2135
pubmed: 29143747
JAMA. 2018 Jul 10;320(2):146-155
pubmed: 29998336
Arch Intern Med. 1987 Sep;147(9):1561-4
pubmed: 3632164

Auteurs

Katie Baca-Motes (K)

Scripps Research Translational Institute, 3344 N Torrey Pines Ct, Plaza Level, La Jolla, CA, 92037, USA.
Wave Research Center, 8330 W Third St, Los Angeles, CA, 90048, USA.

Alison M Edwards (AM)

Healthagen Outcomes, 123 N Wacker Dr STE 650, Chicago, IL, 60606, USA.

Jill Waalen (J)

Scripps Research Translational Institute, 3344 N Torrey Pines Ct, Plaza Level, La Jolla, CA, 92037, USA.

Shawn Edmonds (S)

Healthagen Outcomes, 123 N Wacker Dr STE 650, Chicago, IL, 60606, USA.

Rajesh R Mehta (RR)

Healthagen Outcomes, 123 N Wacker Dr STE 650, Chicago, IL, 60606, USA.

Lauren Ariniello (L)

Scripps Research Translational Institute, 3344 N Torrey Pines Ct, Plaza Level, La Jolla, CA, 92037, USA.
Wave Research Center, 8330 W Third St, Los Angeles, CA, 90048, USA.

Gail S Ebner (GS)

Scripps Research Translational Institute, 3344 N Torrey Pines Ct, Plaza Level, La Jolla, CA, 92037, USA.
Wave Research Center, 8330 W Third St, Los Angeles, CA, 90048, USA.

Dimitri Talantov (D)

Janssen Scientific Affairs, 1125 Trenton-Harbourton Rd, PO Box 200, Titusville, NJ, 08560, USA.

John M Fastenau (JM)

Janssen Scientific Affairs, 1125 Trenton-Harbourton Rd, PO Box 200, Titusville, NJ, 08560, USA.

Chureen T Carter (CT)

Janssen Scientific Affairs, 1125 Trenton-Harbourton Rd, PO Box 200, Titusville, NJ, 08560, USA.

Troy C Sarich (TC)

Janssen Scientific Affairs, 1125 Trenton-Harbourton Rd, PO Box 200, Titusville, NJ, 08560, USA.

Elise Felicione (E)

Janssen Scientific Affairs, 1125 Trenton-Harbourton Rd, PO Box 200, Titusville, NJ, 08560, USA.

Eric J Topol (EJ)

Scripps Research Translational Institute, 3344 N Torrey Pines Ct, Plaza Level, La Jolla, CA, 92037, USA.
Wave Research Center, 8330 W Third St, Los Angeles, CA, 90048, USA.

Steven R Steinhubl (SR)

Scripps Research Translational Institute, 3344 N Torrey Pines Ct, Plaza Level, La Jolla, CA, 92037, USA.
Wave Research Center, 8330 W Third St, Los Angeles, CA, 90048, USA.

Classifications MeSH